Furthermore, hypoglycemic agents such as metformin, thiazolidinediones (TZD), dipeptidyl peptidase-4 (DPP-4) inhibitor were also confirmed to be associated with anemia (31–35). This evidence concerns the gene DPP4 and anemia.